Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Araliadiol protects skin cells from damage by boosting antioxidant defenses.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Monoclonal antibodies are often linked to alopecia areata cases.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Adiantum capillus extract reduces pain and swelling in animals.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Upadacitinib improved multiple immune-related conditions in one patient.

Treatment improved scalp conditions and hair loss with no recurrence after 1 year.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

A new treatment for hair loss shows promise with fewer side effects.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Alcohol dependence affects stress hormone levels more than childhood maltreatment.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.